Netherlands

Covid Vaccine Contender CureVac has tripled his debut

“O.itemList.length” “- this.config.text.ariaShown “This.config.text.ariaFermé” (Bloomberg) – CureVac BV rose 249% on its advertising debut after raising $213 million in an IPO in the United States, which made its profile in the race for a coronavirus vaccine. It was the best first-day performance by a wide margin among about 200 new listings on U.S. exchanges this

Covid Vaccine Contender CureVac has tripled his debut Read More »